跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 270 条关于
“ALKINDI SPRINKLE”
全部
270
临床试验
237
药物
11
机构
1
资讯
21
2年前
Eton Pharmaceuticals Submits NDA to FDA for ET-400 (Hydrocortisone Oral Solution)
2年前
Eton Pharmaceuticals' ET-400 (Hydrocortisone Oral Solution) Receives FDA Acceptance
去年
Eton Pharmaceuticals Receives FDA Approval for KHINDIVI, First Hydrocortisone Oral Solution for Pediatric Adrenal Insufficiency
去年
Eton Pharmaceuticals Acquires U.S. Rights to Amglidia for Neonatal Diabetes
去年
FDA Extends Review Period for Eton Pharmaceuticals' Rare Disease Drug ET-400
去年
Eton Pharmaceuticals' ET-600 Meets Bioequivalence Endpoints for Central Diabetes Insipidus Treatment
去年
ESTEVE Acquires Global Rights to Increlex for Rare Growth Disorder Treatment
6个月前
FDA Approves First Oral Liquid Desmopressin Solution for Central Diabetes Insipidus
去年
FDA Approves Doptelet for Pediatric Immune Thrombocytopenia with New Sprinkle Formulation
去年
Laxxon Medical's Oral GLP-1 Agonist LXM.2 Shows Promise in Pilot Study
第 1 页,共 3 页
上一页
下一页